首页> 外国专利> Modulation of TH1/TH2 cytokine expression by ribavirin and ribavirin analogs in activated t-lymphocytes

Modulation of TH1/TH2 cytokine expression by ribavirin and ribavirin analogs in activated t-lymphocytes

机译:病毒唑和病毒唑类似物在活化的t淋巴细胞中对TH1 / TH2细胞因子表达的调节

摘要

Ribavirin is administered to a patient in a dosage range which is effective to modulate lymphokine expression in activated T cells. In particular, Ribavirin is used to suppress Th2-mediated T cell responses and promote Th1 -mediated T cell responses. In other aspects of the invention, one or more Ribavirin analogs are administered to a patient in a dosage range which is effective to modulate lymphokine expression in activated T cells. The Ribavirin analog(s) may be used to suppress or enhance Th1 or Th2-mediated T cell responses in a viral (e.g. human immunodeficiency virus, hepatitis C virus) and non viral disease (e.g. allergy, autoimmune diseases, helminthic disease, leishmaniasis).
机译:利巴韦林以有效调节活化的T细胞中淋巴因子表达的剂量范围施用于患者。特别地,利巴韦林用于抑制Th2介导的T细胞应答并促进Th1介导的T细胞应答。在本发明的其他方面,将一种或多种利巴韦林类似物以有效调节活化的T细胞中淋巴因子表达的剂量范围施用于患者。利巴韦林类似物可用于抑制或增强病毒(例如人免疫缺陷病毒,丙型肝炎病毒)和非病毒性疾病(例如过敏,自身免疫性疾病,蠕虫病,利什曼病)中的Th1或Th2介导的T细胞应答。 。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号